Prof. Dr. Heisig - Vita
Professor of Pharmaceutical Biology and Microbiology; Head of Pharmaceutical Biology and Microbiology
Qualifikation und Beruflicher Werdegang
1979
1. Staatsexamen Pharmazie
Freie Universität Berlin
1981
2. Staatsexamen Pharmazie
Freie Universität Berlin
1987
Promotion (Microbiology, Molecular Genetics)
Max-Planck Institute of Molecular Genetics/ Rheinische Friedrich-Wilhelms-Universität Bonn
1997
Habilitation (Pharmaceutical Biology & Microbiology)
Rheinische Friedrich-Wilhelms-Universität Bonn
Positionen und Auszeichnungen
1992
Assistant Professor for Pharmaceutical Microbiology, Rheinische Friedrich-Wilhelms-Universität Bonn
1992
Scientific award of the Paul-Ehrlich-Society for Chemotherapy e.V.
1996
Visiting scientist National Center of Healthcare (CISEI) in Cuernavaca, Mexico
1996
Rhône-Poulenc-Rorer-Travel Award, 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., USA
1997
Associate Professor Pharmaceutical Biology and Microbiology, Rheinische Friedrich-Wilhelms-Universität Bonn
1998
Member of the Working Group „Drugs manufactured by gene technology“ of the Federal Pharmacopoea Commission Federal Institute for Drugs and Medicinal Devices
seit 1999
Head of the Committee „Microbiology“of the Federal Pharmacopoea Commission Federal Institute for Drugs and Medicinal Devices
2000
BioGenTec-Initiative North-Rhine-Westfalia
seit 2000
Head of the Working Group Moleculare Methods for Susceptibility Testing of the Paul Ehrlich-Society
seit 2000
Full Professor Pharmaceutical Biology and Microbiology, University of Hamburg
2001
JT Smith Award, 7th International Quinolone Congress, Edinburgh, UK
2003
Lilly Innovation Award, National Congress for Infectious- and Tropical Diseases, Berlin
2004-2007
Director of the Institute of Pharmacy, Hamburg
seit 2008
Member of the Group of Experts of the European Committee for Antibiotc Susceptibility Testing (EUCAST)
2009
Visiting scientist School of Veterinary Science, University of Queensland, Australia
